{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:07:49Z","timestamp":1790521669620,"version":"4.1.0"},"reference-count":235,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/ki.2014.285","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T12:39:04Z","timestamp":1408538344000},"page":"281-296","source":"Crossref","is-referenced-by-count":200,"title":["TNF receptors: signaling pathways and contribution to renal dysfunction"],"prefix":"10.1016","volume":"87","author":[{"given":"Rafia S.","family":"Al-Lamki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya N.","family":"Mayadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.285_bb0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4049\/jimmunol.138.3.957","article-title":"Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages","volume":"138","author":"Decker","year":"1987","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ki.5002132","article-title":"Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury","volume":"71","author":"Dong","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/ki.2014.285_bb0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(91)80803-B","article-title":"Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level","volume":"285","author":"Fiers","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1038\/ki.2014.285_bb0035","first-page":"272","article-title":"Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits","volume":"65","author":"Tipping","year":"1991","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2014.285_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00011-011-0412-8","article-title":"Angiotensin II induces tumor necrosis factor-alpha expression and release from cultured human podocytes","volume":"61","author":"Rosa","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1038\/ki.2014.285_bb0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ki.1989.98","article-title":"Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide","volume":"35","author":"Baud","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0050","first-page":"471","article-title":"The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat kidney after treatment with lipopolysaccharide","volume":"74","author":"Kita","year":"1993","journal-title":"Int J Exp Pathol"},{"key":"10.1038\/ki.2014.285_bb0055","first-page":"1159","article-title":"Tumor necrosis factor-alpha mRNA expression in lipopolysaccharide-stimulated rat kidney. Chronological analysis of localization","volume":"144","author":"Noiri","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0060","doi-asserted-by":"crossref","first-page":"F289","DOI":"10.1152\/ajprenal.00023.2005","article-title":"Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release","volume":"289","author":"Zager","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0065","first-page":"F148","article-title":"Angiotensin II induces TNF production by the thick ascending limb: functional implications","volume":"274","author":"Ferreri","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2014.285_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ki.1994.250","article-title":"TNF production by the medullary thick ascending limb of Henle's loop","volume":"46","author":"Macica","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0075","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/ndt\/10.12.2192","article-title":"Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis","volume":"10","author":"Tikkanen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb0080","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","article-title":"Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies","volume":"87","author":"Brockhaus","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.285_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1043-4666(90)90022-L","article-title":"Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences","volume":"2","author":"Dembic","year":"1990","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0090","doi-asserted-by":"crossref","first-page":"20131","DOI":"10.1016\/S0021-9258(17)30479-9","article-title":"Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells","volume":"265","author":"Loetscher","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/cyto.1995.0082","article-title":"Dimerization of chimeric erythropoietin\/75kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75kDa-TNF receptor transmembrane domain","volume":"7","author":"Declercq","year":"1995","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0100","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","article-title":"Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor","volume":"268","author":"Tartaglia","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0105","first-page":"8","article-title":"Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF","volume":"47","author":"Grell","year":"1995","journal-title":"J Inflamm"},{"key":"10.1038\/ki.2014.285_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2353\/ajpath.2010.091218","article-title":"Tumor necrosis factor receptor expression and signaling in renal cell carcinoma","volume":"177","author":"Al-Lamki","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/labinvest.3780364","article-title":"Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants","volume":"81","author":"Al-Lamki","year":"2001","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2014.285_bb0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1681\/ASN.2007060706","article-title":"TL1A both promotes and protects from renal inflammation and injury","volume":"19","author":"Al-Lamki","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0125","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fj.05-3841com","article-title":"TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury","volume":"19","author":"Al-Lamki","year":"2005","journal-title":"FASEB J"},{"key":"10.1038\/ki.2014.285_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/labinvest.2010.199","article-title":"TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha","volume":"91","author":"Bruggeman","year":"2011","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2014.285_bb0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1600-6143.2008.02536.x","article-title":"Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection","volume":"9","author":"Hoffmann","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2014.285_bb0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.immuni.2013.01.012","article-title":"Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment","volume":"38","author":"Venkatesh","year":"2013","journal-title":"Immunity"},{"key":"10.1038\/ki.2014.285_bb0145","doi-asserted-by":"crossref","first-page":"21151","DOI":"10.1074\/jbc.271.35.21151","article-title":"Human tumor necrosis factor receptor p75\/80 (CD120b) gene structure and promoter characterization","volume":"271","author":"Santee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI200523348","article-title":"Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis","volume":"115","author":"Vielhauer","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.285_bb0155","first-page":"1041","article-title":"Recent advances in the molecular basis of TNF signal transduction","volume":"79","author":"Ledgerwood","year":"1999","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2014.285_bb0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.283.5401.543","article-title":"Prevention of constitutive TNF receptor 1 signaling by silencer of death domains","volume":"283","author":"Jiang","year":"1999","journal-title":"Science"},{"key":"10.1038\/ki.2014.285_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"key":"10.1038\/ki.2014.285_bb0170","doi-asserted-by":"crossref","first-page":"19935","DOI":"10.1074\/jbc.271.33.19935","article-title":"Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins","volume":"271","author":"Takeuchi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1038\/ki.2014.285_bb0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(94)90532-0","article-title":"A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor","volume":"78","author":"Rothe","year":"1994","journal-title":"Cell"},{"key":"10.1038\/ki.2014.285_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","article-title":"Mitogen-activated protein kinase pathways","volume":"9","author":"Robinson","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1098\/rstb.1996.0008","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"351","author":"Karin","year":"1996","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1038\/ki.2014.285_bb0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)61708-7","article-title":"New insights into the role of nuclear factor-kappaB in cell growth regulation","volume":"159","author":"Chen","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0200","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"key":"10.1038\/ki.2014.285_bb0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/ki.2014.285_bb0210","first-page":"159","article-title":"Activation and injury of endothelial cells by cytokines","volume":"46","author":"Pober","year":"1998","journal-title":"Pathol Biol (Paris)"},{"key":"10.1038\/ki.2014.285_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jcp.10080","article-title":"Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer","volume":"191","author":"Tobiume","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1038\/ki.2014.285_bb0220","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/01.RES.0000130525.37646.a7","article-title":"Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner","volume":"94","author":"Zhang","year":"2004","journal-title":"Circ Res"},{"key":"10.1038\/ki.2014.285_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/358417a0","article-title":"Raf-1 activates MAP kinase-kinase","volume":"358","author":"Kyriakis","year":"1992","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0230","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/ki.2014.285_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14728222.7.4.559","article-title":"Cellular FLICE-inhibitory protein: an attractive therapeutic target?","volume":"7","author":"Micheau","year":"2003","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/ki.2014.285_bb0240","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J"},{"key":"10.1038\/ki.2014.285_bb0245","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/scisignal.3115re4","article-title":"The role of the kinases RIP1 and RIP3 in TNF-induced necrosis","volume":"3","author":"Vandenabeele","year":"2010","journal-title":"Sci Signal"},{"key":"10.1038\/ki.2014.285_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cr.2013.171","article-title":"Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res"},{"key":"10.1038\/ki.2014.285_bb0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1038\/ki.2014.285_bb0265","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.03-0771fje","article-title":"Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes","volume":"18","author":"Schwabe","year":"2004","journal-title":"FASEB J"},{"key":"10.1038\/ki.2014.285_bb0270","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/MCB.22.10.3415-3424.2002","article-title":"Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis","volume":"22","author":"Gabai","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trim.2011.04.004","article-title":"Donor or recipient TNF-A -308G\/A polymorphism and acute rejection of renal allograft: A meta-analysis","volume":"25","author":"Hu","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1038\/ki.2014.285_bb0280","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","article-title":"NF-kappaB signals induce the expression of c-FLIP","volume":"21","author":"Micheau","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0285","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0290","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1074\/jbc.M908925199","article-title":"A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor","volume":"275","author":"Duriez","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1165\/rcmb.2003-0384OC","article-title":"Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells","volume":"31","author":"Wadgaonkar","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1038\/ki.2014.285_bb0300","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0092-8674(95)90149-3","article-title":"The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins","volume":"83","author":"Rothe","year":"1995","journal-title":"Cell"},{"key":"10.1038\/ki.2014.285_bb0305","doi-asserted-by":"crossref","first-page":"31572","DOI":"10.1074\/jbc.M504849200","article-title":"Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site","volume":"280","author":"Grech","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0310","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1074-7613(00)80152-1","article-title":"Regulated commitment of TNF receptor signaling: a molecular switch for death or activation","volume":"11","author":"Pimentel-Muinos","year":"1999","journal-title":"Immunity"},{"key":"10.1038\/ki.2014.285_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","article-title":"The death domain kinase RIP mediates the TNF-induced NF-kappaB signal","volume":"8","author":"Kelliher","year":"1998","journal-title":"Immunity"},{"issue":"Suppl 3","key":"10.1038\/ki.2014.285_bb0320","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1186\/ar569","article-title":"Signaling for survival and apoptosis in the immune system","volume":"4","author":"Mak","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1038\/ki.2014.285_bb0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-kappaB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"10.1038\/ki.2014.285_bb0330","doi-asserted-by":"crossref","first-page":"51267","DOI":"10.1074\/jbc.M310678200","article-title":"Etk\/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0335","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1073\/pnas.95.7.3644","article-title":"Etk\/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells","volume":"95","author":"Qiu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.285_bb0340","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.86.24.9936","article-title":"Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways","volume":"86","author":"Fujita","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.285_bb0345","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1084\/jem.166.4.1180","article-title":"Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression","volume":"166","author":"Leeuwenberg","year":"1987","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2014.285_bb0350","doi-asserted-by":"crossref","first-page":"50615","DOI":"10.1074\/jbc.M303680200","article-title":"Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta","volume":"278","author":"Tliba","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0355","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ni1576","article-title":"TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes","volume":"9","author":"Yarilina","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2014.285_bb0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PAP.0b013e318248b7a1","article-title":"Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases","volume":"19","author":"Kambham","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/ki.2014.285_bb0365","first-page":"419","article-title":"Tumor necrosis factor induces glomerular damage in the rabbit","volume":"134","author":"Bertani","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0370","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.4049\/jimmunol.142.9.3083","article-title":"Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1","volume":"142","author":"Tomosugi","year":"1989","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0375","first-page":"1625","article-title":"Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice","volume":"78","author":"Le Hir","year":"1998","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2014.285_bb0380","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/01.ASN.0000073902.38428.33","article-title":"Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis","volume":"14","author":"Timoshanko","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0385","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/16.3.518","article-title":"Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha","volume":"16","author":"Karkar","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb0390","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1523-1755.2005.00279.x","article-title":"Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis","volume":"67","author":"Khan","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0395","doi-asserted-by":"crossref","first-page":"e68167","DOI":"10.1371\/journal.pone.0068167","article-title":"Distinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice","volume":"8","author":"Taubitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/ki.2014.285_bb0400","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1084\/jem.183.5.2367","article-title":"Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling","volume":"183","author":"Le Hir","year":"1996","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2014.285_bb0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1600-065X.2003.00071.x","article-title":"Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting","volume":"195","author":"Tumanov","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1038\/ki.2014.285_bb0410","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1000740","article-title":"TNF receptor-1 is required for the formation of splenic compartments during adult, but not embryonic life","volume":"186","author":"Milicevic","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0415","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/372560a0","article-title":"Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice","volume":"372","author":"Erickson","year":"1994","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0420","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","article-title":"Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1038\/ki.2014.285_bb0425","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/ki.2014.285_bb0430","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2014.285_bb0435","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/ki.2014.285_bb0440","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3346\/jkms.2013.28.2.261","article-title":"Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis","volume":"28","author":"Zwiech","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1038\/ki.2014.285_bb0445","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/ndt\/gfq310","article-title":"Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis","volume":"25","author":"Idasiak-Piechocka","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0455","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2005060616","article-title":"Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis","volume":"17","author":"Little","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0460","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/01.ASN.0000016442.33680.3E","article-title":"ANCA-positive vasculitis","volume":"13","author":"Kamesh","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0465","doi-asserted-by":"crossref","first-page":"c222","DOI":"10.1159\/000235242","article-title":"Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis","volume":"113","author":"Hasegawa","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2014.285_bb0470","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1993.98","article-title":"In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis","volume":"43","author":"Noronha","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0475","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/13.7.1662","article-title":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","volume":"13","author":"Tesar","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb0480","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000088313","article-title":"Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis","volume":"102","author":"Ito-Ihara","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2014.285_bb0485","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.285_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1191\/0961203305lu2053oa","article-title":"Cytokine expression in lupus kidneys","volume":"14","author":"Aringer","year":"2005","journal-title":"Lupus"},{"key":"10.1038\/ki.2014.285_bb0495","doi-asserted-by":"crossref","first-page":"365083","DOI":"10.1155\/2010\/365083","article-title":"Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances","volume":"2010","author":"Yap","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1038\/ki.2014.285_bb0500","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0046-8177(95)90253-8","article-title":"Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients","volume":"26","author":"Malide","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1038\/ki.2014.285_bb0505","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.156.8.3043","article-title":"Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3\u2032-untranslated region in the genetic predisposition to lupus-like autoimmune disease","volume":"156","author":"Jacob","year":"1996","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0510","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/331356a0","article-title":"Tumour necrosis factor-alpha in murine autoimmune \u2018lupus\u2019 nephritis","volume":"331","author":"Jacob","year":"1988","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0515","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.gene.6363783","article-title":"Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test","volume":"2","author":"Tsuchiya","year":"2001","journal-title":"Genes Immun"},{"key":"10.1038\/ki.2014.285_bb0520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1191\/0961203302lu160oa","article-title":"Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death","volume":"11","author":"Aringer","year":"2002","journal-title":"Lupus"},{"key":"10.1038\/ki.2014.285_bb0525","first-page":"1473","article-title":"A bridge between interferon-alpha and tumor necrosis factor in lupus","volume":"35","author":"Aringer","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1038\/ki.2014.285_bb0530","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.141.9.3050","article-title":"Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis","volume":"141","author":"Boswell","year":"1988","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0535","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.0802948","article-title":"Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway","volume":"182","author":"Jacob","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0540","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.34553","article-title":"Anti-tumor necrosis factor alpha treatment of interferon-alpha-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation","volume":"64","author":"Bethunaickan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2014.285_bb0545","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.143.11.3470","article-title":"Tumor necrosis factor and IL-1 in New Zealand Black\/White mice. Enhanced gene expression and acceleration of renal injury","volume":"143","author":"Brennan","year":"1989","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0550","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/1043-4666(91)90481-R","article-title":"Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation","volume":"3","author":"Jacob","year":"1991","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0555","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.V1181426","article-title":"Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis","volume":"11","author":"Aten","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0560","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","article-title":"Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis","volume":"179","author":"Wu","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0565","first-page":"303","article-title":"Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity","volume":"24","author":"Gabay","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1038\/ki.2014.285_bb0570","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cyto.2012.07.004","article-title":"Serum cytokine profile in patients with active lupus nephritis","volume":"60","author":"Koenig","year":"2012","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors","volume":"175","author":"Aderka","year":"1992","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2014.285_bb0580","first-page":"BR24","article-title":"Soluble cytokine receptors in renal vasculitis and lupus nephritis","volume":"8","author":"Tesar","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1038\/ki.2014.285_bb0585","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clinbiochem.2004.11.002","article-title":"Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus","volume":"38","author":"Mahmoud","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1038\/ki.2014.285_bb0590","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1399-0039.1999.530602.x","article-title":"Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus","volume":"53","author":"Komata","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1038\/ki.2014.285_bb0595","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1074\/jbc.M411541200","article-title":"The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression","volume":"280","author":"Till","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.285_bb0600","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cytogfr.2009.02.005","article-title":"Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy","volume":"20","author":"Navarro-Gonzalez","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/ki.2014.285_bb0605","doi-asserted-by":"crossref","first-page":"F113","DOI":"10.1152\/ajprenal.00026.2002","article-title":"Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes","volume":"284","author":"DiPetrillo","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0610","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00592-007-0007-6","article-title":"Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats","volume":"44","author":"Moriwaki","year":"2007","journal-title":"Acta Diabetol"},{"key":"10.1038\/ki.2014.285_bb0615","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1161\/01.CIR.98.23.2621","article-title":"Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats","volume":"98","author":"Yu","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2014.285_bb0620","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1073\/pnas.97.14.7667","article-title":"Transforming growth factor beta contributes to progressive diabetic nephropathy","volume":"97","author":"Reeves","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.285_bb0625","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1152\/ajprenal.00509.2013","article-title":"The role of the TNF pathway in progression of diabetic nephropathy in KK-A(y) mice","volume":"306","author":"Omote","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0630","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI11771","article-title":"Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice","volume":"108","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.285_bb0635","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1681\/ASN.2011060628","article-title":"Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes","volume":"23","author":"Gohda","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0640","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb0645","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1523-1755.2000.00310.x","article-title":"Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules","volume":"58","author":"Choi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0650","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1797.1996.tb00082.x","article-title":"The expression of mRNA for tumour necrosis factor-\u03b1 increases in the obstructed kidney of rats soon after unilateral ureteral ligation","volume":"2","author":"Kaneto","year":"2007","journal-title":"Nephrology"},{"key":"10.1038\/ki.2014.285_bb0655","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2353\/ajpath.2009.080884","article-title":"Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats","volume":"175","author":"Misaki","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0660","first-page":"F766","article-title":"Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy","volume":"277","author":"Guo","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2014.285_bb0665","doi-asserted-by":"crossref","first-page":"R1456","DOI":"10.1152\/ajpregu.00620.2005","article-title":"TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction","volume":"292","author":"Meldrum","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1038\/ki.2014.285_bb0670","doi-asserted-by":"crossref","first-page":"F406","DOI":"10.1152\/ajprenal.00099.2004","article-title":"TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling","volume":"288","author":"Misseri","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0675","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yexmp.2008.08.003","article-title":"TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction","volume":"85","author":"Morimoto","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/ki.2014.285_bb0680","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bcp.2007.01.010","article-title":"Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity","volume":"73","author":"Jiang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/ki.2014.285_bb0685","doi-asserted-by":"crossref","first-page":"F610","DOI":"10.1152\/ajprenal.00101.2003","article-title":"TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure","volume":"285","author":"Ramesh","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0690","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2012.11.066","article-title":"The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-alphaR1: a comparison with infliximab treatment","volume":"700","author":"Di Paola","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/ki.2014.285_bb0695","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000060075","article-title":"Pathophysiology of ischemic acute renal failure","volume":"132","author":"Sheridan","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1038\/ki.2014.285_bb0700","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","article-title":"Clinical development of platinum complexes in cancer therapy: an historical perspective and an update","volume":"34","author":"Lebwohl","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1038\/ki.2014.285_bb0705","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/019262338501300406","article-title":"Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat: enzyme histochemical studies","volume":"13","author":"Jones","year":"1985","journal-title":"Toxicol Pathol"},{"key":"10.1038\/ki.2014.285_bb0710","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1523-1755.2004.09109.x","article-title":"Inflammatory cytokines in acute renal failure","volume":"91","author":"Ramesh","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2014.285_bb0715","doi-asserted-by":"crossref","first-page":"F546","DOI":"10.1152\/ajprenal.00072.2006","article-title":"Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response","volume":"291","author":"Zager","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0720","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.285_bb0725","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ki.5002242","article-title":"Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0730","doi-asserted-by":"crossref","first-page":"F208","DOI":"10.1152\/ajprenal.00311.2002","article-title":"Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways","volume":"285","author":"Tsuruya","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0735","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1432-2277.2006.00376.x","article-title":"Gene expression and biomarkers in renal transplant ischemia reperfusion injury","volume":"20","author":"Perco","year":"2007","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2014.285_bb0740","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/08860229809045135","article-title":"Nitric oxide-mediated renal epithelial cell injury during hypoxia and reoxygenation","volume":"20","author":"Paller","year":"1998","journal-title":"Ren Fail"},{"key":"10.1038\/ki.2014.285_bb0745","doi-asserted-by":"crossref","DOI":"10.1007\/s00795-013-0067-3","article-title":"Renal atrophy after ischemia-reperfusion injury depends on massive tubular apoptosis induced by TNFalpha in the later phase","author":"Adachi","year":"2014","journal-title":"Med Mol Morphol"},{"key":"10.1038\/ki.2014.285_bb0750","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1189\/jlb.0706480","article-title":"Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha","volume":"81","author":"Esposito","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2014.285_bb0755","doi-asserted-by":"crossref","first-page":"F1334","DOI":"10.1152\/ajprenal.00431.2011","article-title":"Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and \"end-stage\" kidney disease","volume":"301","author":"Zager","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.285_bb0760","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.transproceed.2009.05.042","article-title":"Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury","volume":"41","author":"Choi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2014.285_bb0765","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.TP.0000164348.16689.03","article-title":"Markers of inflammation before and after renal transplantation","volume":"80","author":"Cueto-Manzano","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0770","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1084\/jem.166.4.1132","article-title":"Raised serum levels of cachectin\/tumor necrosis factor alpha in renal allograft rejection","volume":"166","author":"Maury","year":"1987","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2014.285_bb0775","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00007890-199106000-00015","article-title":"Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients","volume":"51","author":"McLaughlin","year":"1991","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0780","first-page":"1289","article-title":"Tumour necrosis factor in renal transplantation","volume":"23","author":"McLaughlin","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2014.285_bb0785","first-page":"1000","article-title":"Usha, Singh RG. Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases","volume":"20","author":"Sonkar","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1038\/ki.2014.285_bb0790","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00007890-199410150-00013","article-title":"The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection","volume":"58","author":"Dooper","year":"1994","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0795","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature02514","article-title":"The ubiquitin ligase COP1 is a critical negative regulator of p53","volume":"429","author":"Dornan","year":"2004","journal-title":"Nature"},{"key":"10.1038\/ki.2014.285_bb0800","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/TP.0b013e3181938971","article-title":"Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model","volume":"87","author":"Hummel","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0805","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.transproceed.2012.12.006","article-title":"Cytokine gene polymorphisms in kidney transplantation","volume":"45","author":"Dhaouadi","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2014.285_bb0810","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/1319-2442.113855","article-title":"Tumor necrosis factor-alfa and monocyte chemoattractant protein-1 gene polymorphisms in kidney transplant recipients","volume":"24","author":"El-Gezawy","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1038\/ki.2014.285_bb0815","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1523-1755.2004.00936.x","article-title":"Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy","volume":"66","author":"Hoffmann","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0820","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11010-007-9694-0","article-title":"Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation","volume":"311","author":"Manchanda","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1038\/ki.2014.285_bb0825","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.trim.2007.10.003","article-title":"Cytokine gene polymorphism in kidney transplantation\u2014impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome","volume":"18","author":"Nikolova","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1038\/ki.2014.285_bb0830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.1999.00536.x","article-title":"Cytokine gene polymorphisms predict acute graft rejection following renal transplantation","volume":"56","author":"Sankaran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0835","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.TP.0000134768.82277.CB","article-title":"Impaired kidney graft survival is associated with the TNF-alpha genotype","volume":"78","author":"Wramner","year":"2004","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0840","first-page":"528","article-title":"Cytokine gene polymorphisms in renal transplant recipients","volume":"4","author":"Azarpira","year":"2006","journal-title":"Exp Clin Transplant"},{"key":"10.1038\/ki.2014.285_bb0845","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.tp.0000184624.54005.9f","article-title":"Immune response gene polymorphisms in renal transplant recipients","volume":"80","author":"Dmitrienko","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0850","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.transproceed.2005.03.151","article-title":"Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression","volume":"37","author":"Loucaidou","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2014.285_bb0855","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cyto.2011.12.006","article-title":"Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation","volume":"57","author":"Reinhold","year":"2012","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0860","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/TP.0b013e3181891d8b","article-title":"Endothelial cells in allograft rejection","volume":"86","author":"Al-Lamki","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0865","first-page":"27","article-title":"Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells","volume":"146","author":"Bradley","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2014.285_bb0870","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2009.142","article-title":"Immunoregulatory role of TNFalpha in inflammatory kidney diseases","volume":"76","author":"Ernandez","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.285_bb0875","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.168.1.483","article-title":"Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity","volume":"168","author":"McKee","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.285_bb0880","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-3089.2011.00634.x","article-title":"Identification of soluble and membrane-bound isoforms of porcine tumor necrosis factor receptor 2","volume":"18","author":"Uribe-Herranz","year":"2011","journal-title":"Xenotransplantation"},{"key":"10.1038\/ki.2014.285_bb0885","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00007890-199801150-00022","article-title":"Delayed rejection of soluble tumor necrosis factor receptor-secreting tumor allografts","volume":"65","author":"Sabatine","year":"1998","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0890","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000320467","article-title":"The role of tumor necrosis factor-alpha converting enzyme in renal transplant rejection","volume":"32","author":"Wang","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2014.285_bb0895","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo","volume":"89","author":"Van Zee","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.285_bb0900","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1432-2277.2002.tb00175.x","article-title":"sTNF-RII: is it useful for the early diagnosis of rejection and for prognosis after renal transplantation?","volume":"15","author":"Diller","year":"2002","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2014.285_bb0905","first-page":"425","article-title":"[Expression of IL6 and TNF-alpha in normal and pathological kidney]","volume":"187","author":"Boucher","year":"1993","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1038\/ki.2014.285_bb0910","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00007890-199101000-00008","article-title":"The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection","volume":"51","author":"Imagawa","year":"1991","journal-title":"Transplantation"},{"key":"10.1038\/ki.2014.285_bb0915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/ki.2014.285_bb0920","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s001200050311","article-title":"[Molecular genetics and diagnosis of renal cell tumors]","volume":"38","author":"Kovacs","year":"1999","journal-title":"Urologe A"},{"key":"10.1038\/ki.2014.285_bb0925","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cyto.2004.10.016","article-title":"Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma","volume":"30","author":"Basturk","year":"2005","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb0930","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.onc.1205140","article-title":"Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity","volume":"21","author":"Caldwell","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/ki.2014.285_bb0935","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/MCB.23.7.2316-2328.2003","article-title":"von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays","volume":"23","author":"Galban","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0940","first-page":"7076","article-title":"The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway","volume":"63","author":"Qi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/ki.2014.285_bb0945","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: a master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front Biosci"},{"key":"10.1038\/ki.2014.285_bb0950","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: how hot is the link?","volume":"72","author":"Aggarwal","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/ki.2014.285_bb0955","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/ki.2014.285_bb0960","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1349-7006.2008.00756.x","article-title":"Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells","volume":"99","author":"Chuang","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1038\/ki.2014.285_bb0965","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1158\/1541-7786.MCR-12-0160","article-title":"TNF-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3beta-dependent mechanism","volume":"10","author":"Ho","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1038\/ki.2014.285_bb0970","first-page":"317","article-title":"TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma","volume":"20","author":"Ikemoto","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1038\/ki.2014.285_bb0975","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1258\/ebm.2011.011058","article-title":"Tumor necrosis factor-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism","volume":"236","author":"Wu","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1038\/ki.2014.285_bb0980","first-page":"1883","article-title":"Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid","volume":"18","author":"Elsasser-Beile","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1038\/ki.2014.285_bb0985","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1128\/MCB.22.21.7512-7523.2002","article-title":"Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis","volume":"22","author":"Pan","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2014.285_bb0990","first-page":"1947","article-title":"Effects of tumor necrosis factor alpha in renal cell carcinoma","volume":"10","author":"Ikemoto","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1038\/ki.2014.285_bb0995","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/onc.2011.567","article-title":"Breaking the \u2018harmony\u2019 of TNF-alpha signaling for cancer treatment","volume":"31","author":"Sasi","year":"2012","journal-title":"Oncogene"},{"key":"10.1038\/ki.2014.285_bb1000","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF00209026","article-title":"The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3","volume":"87","author":"Kemper","year":"1991","journal-title":"Hum Genet"},{"key":"10.1038\/ki.2014.285_bb1005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00287055","article-title":"The chromosome changes in non-Burkitt lymphomas","volume":"53","author":"Reeves","year":"1980","journal-title":"Hum Genet"},{"key":"10.1038\/ki.2014.285_bb1010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrd3930","article-title":"Clinical targeting of the TNF and TNFR superfamilies","volume":"12","author":"Croft","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/ki.2014.285_bb1015","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.02181205","article-title":"TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations","volume":"1","author":"Huugen","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.285_bb1020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.285_bb1025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/keh483","article-title":"Anti-TNF-alpha therapies: they are all the same (aren't they)?","volume":"44","author":"Mpofu","year":"2005","journal-title":"Rheumatology"},{"key":"10.1038\/ki.2014.285_bb1030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/ki.2014.285_bb1035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","article-title":"Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha","volume":"128","author":"Mitoma","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/ki.2014.285_bb1040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1043-4666(03)00201-1","article-title":"The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures","volume":"23","author":"Agnholt","year":"2003","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb1045","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn\u2019s disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1038\/ki.2014.285_bb1050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cyto.2004.06.008","article-title":"Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes","volume":"28","author":"Kirchner","year":"2004","journal-title":"Cytokine"},{"key":"10.1038\/ki.2014.285_bb1055","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/ndt\/gfq187","article-title":"Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement","volume":"25","author":"Laurino","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb1060","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2014.285_bb1065","first-page":"416","article-title":"Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients","volume":"27","author":"Matsumura","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2014.285_bb1070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/rheumatology\/kep270","article-title":"Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients","volume":"48","author":"Aringer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/ki.2014.285_bb1075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE-promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1038\/ki.2014.285_bb1080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep080","article-title":"Anti-TNF-induced lupus","volume":"48","author":"Williams","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/ki.2014.285_bb1085","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb1090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2011.04.032","article-title":"Epidemiology and management of refractory lupus nephritis","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"Suppl 2","key":"10.1038\/ki.2014.285_bb1095","doi-asserted-by":"crossref","first-page":"ii70","DOI":"10.1136\/ard.61.suppl_2.ii70","article-title":"Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials","volume":"61","author":"Rau","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2014.285_bb1100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1572-0241.2005.40647.x","article-title":"Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab","volume":"100","author":"Papadakis","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/ki.2014.285_bb1105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/03009740510026887","article-title":"Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital","volume":"34","author":"Wick","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1038\/ki.2014.285_bb1110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.diabres.2011.01.008","article-title":"Association between serum soluble TNFalpha receptors and renal dysfunction in type 2 diabetic patients without proteinuria","volume":"92","author":"Miyazawa","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1038\/ki.2014.285_bb1115","first-page":"262","article-title":"[TNF-alpha receptors (TNFRS): the biomarkers of progressive diabetic nephropathy we were waiting for?]","volume":"29","author":"Bolignano","year":"2012","journal-title":"G Ital Nefrol"},{"key":"10.1038\/ki.2014.285_bb1120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00592-011-0349-y","article-title":"Structural damage in diabetic nephropathy is associated with TNF-alpha system activity","volume":"49","author":"Fernandez-Real","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1038\/ki.2014.285_bb1125","first-page":"815","article-title":"Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection","volume":"9","author":"Keil","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.285_bb1130","first-page":"85","article-title":"Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment","volume":"26","author":"Zaenker","year":"2004","journal-title":"Int J Tissue React"},{"key":"10.1038\/ki.2014.285_bb1135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0272-6386(03)00651-6","article-title":"Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study","volume":"42","author":"Navarro","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.285_bb1140","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1200\/JCO.2007.11.2136","article-title":"Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose","volume":"25","author":"Harrison","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/ki.2014.285_bb1145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.bjc.6605889","article-title":"A phase I\/II trial of sorafenib and infliximab in advanced renal cell carcinoma","volume":"103","author":"Larkin","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/ki.2014.285_bb1150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/07357900701359700","article-title":"Antitumor necrosis factor (TNF-a) antibodies in the treatment of renal cell cancer","volume":"25","author":"Maisey","year":"2007","journal-title":"Cancer Invest"},{"key":"10.1038\/ki.2014.285_bb1155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ibd.20760","article-title":"Modulation of the Th1\/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis","volume":"15","author":"Matsumura","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/ki.2014.285_bb1160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1081\/IPH-120037721","article-title":"Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn's disease: a case report","volume":"26","author":"Principi","year":"2004","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1038\/ki.2014.285_bb1165","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0961203306070970","article-title":"Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy","volume":"15","author":"Micheloud","year":"2006","journal-title":"Lupus"},{"key":"10.1038\/ki.2014.285_bb1170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/s10165-006-0561-8","article-title":"Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus","volume":"17","author":"Hayat","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1038\/ki.2014.285_bb1175","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s10067-006-0357-4","article-title":"Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab","volume":"26","author":"Ahmed","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1038\/ki.2014.285_bb1180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/003655999750016113","article-title":"Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure","volume":"33","author":"Navarro","year":"1999","journal-title":"Scand J Urol Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T04:27:15Z","timestamp":1689481635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815300582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":235,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0085253815300582"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.285","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}